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An algorithm to predict advanced 
proximal colorectal neoplasia in 
Chinese asymptomatic population
Jason Liwen Huang1,*, Ping Chen2,*, Xiaoqin Yuan2, Yunlin Wu2, Harry Haoxiang Wang3 & 
Martin Chisang Wong1,4,5
This study aims to develop and validate a new algorithm that incorporates distal colonoscopic findings 
to predict advanced proximal neoplasia (APN) in a Chinese asymptomatic population. We collected age, 
gender, and colonoscopic findings from a prospectively performed colonoscopy study between 2013 
and 2015 in a large hospital-based endoscopy unit in Shanghai, China. Eligible subjects were allocated 
to a derivation group (n = 3,889) and validation group (n = 1,944) by random sampling. A new index for 
APN and its cut-off level were evaluated from the derivation cohort by binary logistic regression. The 
model performance was tested in the validation cohort using area under the curve (AUC). Age, gender, 
and distal finding were found to be independent predictors of APN in the derivation cohort (p < 0.001). 
Subjects were categorized into Average Risk (AR) and High Risk (HR) based on a cut-off score of 2. 
The AUC of the derivation and validation cohorts were 0.801 (0.754–0.847) and 0.722 (0.649–0.794), 
respectively. In the validation cohort, those in the HR group had a 3.57 fold higher risk of APN when 
compared with the AR group (P < 0.001), requiring 18 (95% CI = 12–28) follow-up colonoscopies to 
detect 1 APN. This new clinical index is useful to stratify APN risk in Chinese population.
Worldwide, colorectal cancer (CRC) is the third most common cancer in males and ranks the second in females, 
with an estimated 1.4 million cases and 693,900 deaths reported in 20121. The increasing incidence and mortality 
of CRC in many low-income and middle-income countries, including China, highlights the pressing need for 
CRC control2. Screening has been proven an effective and cost-efficient strategy to reduce CRC mortality3.
CRC prevention should be the primary goal of screening. Tests that are employed to detect early cancer and 
adenomatous polyps have been recommended for average-risk subjects aged 50 years or above4, and these include 
colonoscopy and flexible sigmoidoscopy (FS). In recent decades, proximal shift of CRC and advanced proximal 
neoplasia (APN) with no distal lesions detected5–9 are increasingly observed, and this has an implication on 
the use of FS in clinical practice. Nevertheless, colonoscopy might not be suited as a primary screening test in 
resource-limited countries with limited colonoscopy capacity10. It may be more cost-effective and cost-saving to 
reserve colonoscopy for subjects with high risk for APN in population-based screening11,12. To address this need, 
Imperiale et al.12 proposed a 7-point scoring system to predict APN by using age, gender, and distal findings at 
FS as predictors and a high discrimination value was reported in its internal validation group. Its generalizability 
remain unknown in Chinese subjects, since the incidence and distribution of colorectal neoplasia are different 
among different ethnic groups13. Levitzky et al. has performed an external validation of the model devised by 
Imperiale et al., and the discriminatory capability was found to be lower in a different population, including 
black and Hispanic11. to the primary objective of this study is to develop and validate a new model specifically 
tailored to predict APN in a Chinese asymptomatic population. We conducted this cross-sectional study in a large 
hospital-based endoscopy unit.
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Results
Descriptive findings. Table 1 showed that the age, gender, and the most advanced distal findings of the 
derivation and validation cohorts were statistically similar (all p-values > 0.05). For the derivation cohort and 
validation cohort, the APN rates were 2.7% (95% CI, 2.2–3.2%) and 2.4% (95% CI, 1.8–3.2%), respectively. The 
Cochran Mantel–Haenszel χ 2 test indicated that age, gender, and distal findings were associated with APN. The 
prevalence of APN in the derivation cohort stratified by these variables was shown in Table 2.
Univariate and multivariate binary logistic regression of advanced proximal neoplasia in the 
derivation group. Univariate and multivariate analyses were performed for each risk factor. Multivariate 
binary logistic regression showed that age above 55 years, male gender, and distal finding of non-advanced ade-
noma and advanced neoplasia were significant risk factors for APN. Hyperplastic polyps in distal colon had 
an OR of 1.6 (0.7 to 3.6) and did not reach significance in this group (Table 3). From the multivariate analyses, 
the ORs (95% CI) of male gender, age (66–75), and distal finding of advanced neoplasia were 1.8(1.2–2.9), 4.7 
(2.1–10.6), and 20.3 (12.4–33.4), respectively.
Development of the risk score. Each risk factor was weighted in points according to the respective 
adjusted OR from binary logistic regression analysis (Table 3). The respective adjusted OR was halved and 
rounded to the nearest whole number14. The new index was generated assigning points to each risk factor for 
APN, according to age, sex and distal findings (Table 4).
The new index has a range of 0 to 13 points based on a summation of scores from each variable. The frequency 
distribution of subjects by new index is shown in Table 5. The cut-off value was determined by analysis of the 
sensitivity, specificity, positive predictive value and positive likelihood ratios for each possible score (Table 6). As a 
screening test, a higher sensitivity will be required. We divided the derivation cohort into two groups of risk: score 
0 to 2 as “average risk” (AR); score > 2 as “high risk” (HR). Based on this stratification, 2,986 subjects (76.8%) 
were in the AR group and 903 subjects (23.2%) in the HR group among the derivation cohort (Table 7). The APN 
rates in AR and HR group were 1.2% (95% CI, 0.8–1.6%) and 7.6% (95% CI, 6.0–9.6%), respectively. The AUC in 
derivation cohort was 0.801 (95% CI, 0.754–0.847).
In validation cohort, the APN rates in AR and HR group were 1.5% (95% CI, 1.0–2.3%) and 5.5% (95% CI, 
3.6–8.1%), respectively (Table 6). Those in the HR group had a 3.57-fold risk of having APN comparing with 
those in AR group (P < 0.001). The number needed to screen for one APN in HR group was 18 (95% CI, 12–28). 
The AUC for the new index was 0.722 (95% CI, 0.649–0.794), indicating good discrimination.
Derivation cohort N = 3,889 Validation cohort N = 1,944 p-value
Age (years), mean ± SD 60.1 ± 6.3 60.1 ± 6.2 0.775
Gender, male, N (%) 1,814 (46.6) 912 (46.9) 0.846
Most Advanced Distal Findings, n(%) 0.725
No polyp 2,705 (69.6) 1,365 (70.2)
Hyperplastic 362 (9.3) 176 (9.1)
Non-advanced Adenoma 642 (16.5) 325 (16.7)
Advanced Neoplasia 180 (4.6) 78 (4.0)
Table 1.  Characteristics of participants in the derivation and validation cohorts.
All subjects APN, n = 104
Prevalence (%) Prevalence (%) p-value
Gender < 0.001
 Male 1,814 (46.6) 71 (3.9)
 Female 2,075 (53.4) 33 (1.6)
Age < 0.001
 50–55 862 (22.2) 7 (0.8)
 56–60 1,066 (27.4) 23 (2.2)
 61–65 975 (25.1) 27 (2.8)
 66–75 986 (25.4) 47 (4.8)
Most Advanced Distal Findings < 0.001
 No polyp 2,705 (69.6) 33 (1.2)
 Hyperplastic 362 (9.3) 7 (1.9)
 Non-advanced 642 (16.5) 21 (3.3)
 Advanced 180 (4.6) 43 (23.9)
Table 2.  Prevalence of advanced proximal neoplasia in the derivation cohort by risk factors. APN: 
Advanced Proximal Neoplasia.
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Discussion
Risk stratification for average risk population in CRC screening offers the potential to improve the 
cost-effectiveness of a screening program, especially for deprived regions with limited resources11,15,16. Moreover, 
risk assessment tools for risk stratification provide tailoring options for individuals, this facilitating their decision 
making in the choice of the screening test14,17,18. Our study focused on prediction of APN, which could serve as an 
algorithm for determining colonoscopy referral among those who have received FS.
There are several risk algorithms devised for prediction of APN13,15,19–25. These risk models used different cri-
teria to estimate the risk of APN. Some used distal findings alone whilst others incorporated additional variables 
with an intention to enhance the score’s discriminatory capability. The possible drawback of the latter types of 
 Unadjusted Adjusted
Risk factors OR (95% CI) p-value βcoefficient SE OR (95% CI) p-value
Gender < 0.001 0.008
 Female Referent Referent
 Male 2.5 (1.7–3.8) 0.604 0.227 1.8 (1.2–2.9)
Age < 0.001 0.001
 50–55 Referent Referent
 56–60 2.7 (1.2–6.3) 0.022 0.914 0.443 2.5 (1.0–5.9) 0.039
 61–65 3.5 (1.5–8.0) 0.003 1.037 0.436 2.8 (1.2–6.6) 0.017
 66–75 6.1 (2.7–13.6) < 0.001 1.545 0.417 4.7 (2.1–10.6) < 0.001
Most advanced distal findings < 0.001 < 0.001
No polyp Referent Referent
Hyperplastic 1.6 (0.7–3.6) 0.265 0.344 0.423 1.4 (0.6–3.2) 0.417
Non-advanced 2.7 (1.6–4.8) < 0.001 0.800 0.289 2.2 (1.3–3.9) 0.006
Advanced 25.4 (15.6–41.3) < 0.001 3.011 0.253
20.3 
(12.4–33.4) < 0.001
Table 3.  Univariate and multivariate predictors of advanced proximal neoplasia in the derivation cohort.
 Risk factor Criteria Points
Age 50–55 0
56–65 1
66–75 2
Gender Female 0
Male 1
Most Advanced Distal Findings
No polyp 0
Hyperplastic polyp 0
Non-advanced adenoma 1
Advanced neoplasia 10
Table 4.  Scoring System for the Risk Index of Advanced Proximal Neoplasia. *A score is generated by 
adding points for age, gender, and most advanced distal findings.
Score
Subjects (Proportion 
of Cohort) with 
Score, n(%)
Subjects with 
Score who had 
APN, n (%) Risk Tier
0 428 (11.0) 2 (0.5)
Average Risk1 1,278 (32.9) 7 (0.5)
2 1,280 (32.9) 26 (2.0)
3 597 (15.4) 20 (3.4)
High Risk
4 126 (3.2) 6 (4.8)
10 9 (0.2) 0 (0.0)
11 46 (1.2) 7 (15.2)
12 85 (2.2) 22 (25.9)
13 40 (1.0) 14 (35.0)
Table 5.  Risk for APN in the derivation cohort, by Index Score. APN: Advanced Proximal Neoplasia.
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algorithms includes the practical difficulties for them to be applied in clinical practice. Hence, the present risk 
score included only three variables that may facilitate its use in real-life screening services.
In our previous study19, we tested the external validation of Imperiale et al. model in the total 5,833 and 
obtained a result of area under curve (AUC) 0.724 (95% CI, 0.685–0.763). We also found that age, gender, and 
distal colon findings were all independent predictors of APN. Consistent with the previous studies20–22, our data 
showed that distal adenomas, but not distal hyperplastic polyps, were associated with increased risk for APN. 
Moreover, distal neoplasia, including advanced neoplasia and non-advanced adenoma, are consistently found to 
be risk factors of APN23. The OR of distal advanced neoplasia for APN was 2.7–3.6 when compared with normal 
distal findings24,25. However, in our study, our adjusted OR for APN conferred by distal advanced findings in mul-
tivariate logistic regression was relatively high (20.3, 95% CI, 12.4–33.4), which may be due to the high proportion 
of older people included in the present cohort. Participants with age over 60 consist of 50.5% of the derivation 
cohort. It is commonly recognized that distal neoplasia detected by FS, including adenoma and advanced neo-
plasia, should be referred for colonoscopy follow-up4,26. In our study (Table 7), the APN rate in the AR group was 
lower than the overall rate. It indicates that women aged 50 to 65 and men aged 50 to 55 who had non-advanced 
adenoma in the distal colon may not be a top priority for follow-up colonoscopy. Soon et al. suggested arranging 
colonoscopy for patients with distal advanced neoplasia to optimize colonoscopy efficiency and yield in Chinese 
communities with limited health-care resources27. Future prospective studies are needed to further quantify the 
risk of APN in different Chinese populations.
Our study has several strengths. First, this was the first study that has used distal finding as a predictor for 
predicting APN in Chinese populations. Second, we included a large cohort of asymptomatic average-risk indi-
viduals and this enables application of this model in future population-based programs. Also, the histopathology 
examinations were performed by the same team of pathologists who were blinded to this study to minimize 
potential biases. Finally we restricted our analyses to those with good and excellent bowel preparations that 
allowed complete observation of the whole colorectum to avoid misclassification.
There are several limitations that should be addressed. Firstly, the sampling methodology in the large 
hospital-based endoscopy unit was not random. Although the quality of endoscopic procedure could be stand-
ardized according to guidelines, the socio-demographic details of the subjects could be different from that of 
the general population. Also, the distal findings for APN prediction were derived from colonoscopy rather than 
FS, which the present study aims to simulate. In addition, other potential risk factors were not available in this 
study, such as family history, body mass index, and smoking status. This requires cautions in interpretation of the 
findings. Theoretically, applying more predictors will optimize the scoring model with higher AUC28 although 
too many factors might limit its practical application. Despite all the limitations, our data showed good discrimi-
nation from the new scoring index in this Chinese population.
Recently, the prognosis of proximal colon cancer continues to be poor as this was first reported since 1980 in 
Switzerland29. In usual clinical practice, proximal colon cancer had a miss rate of 4.0% during colonoscopy test30. 
It could be caused by the smaller size of advanced proximal neoplasia compared with distal one31,32. Thus, the 
present APN prediction model could also inform colonoscopists to raise alert not to miss proximal lesion when 
they encounter distal polyps during the test.
Cutoff Value Sensitivity (%) Specificity (%) PPV(%) PLR
0 98.1 11.3 2.9 1.1
1 91.3 44.8 4.4 1.7
2 66.3 78.0 7.6 3.0
3 47.1 93.2 16.0 6.9
4 41.3 96.4 23.9 11.4
Table 6.  Performance among different cut-off values in the derivation cohort. PPV: Positive Predictive 
Value; PLR: Positive Likelihood Ratios.
Derivation cohort Validation cohort
Risk Tier 
(Risk Score)
Subjects with 
score, n(%)
Subjects with 
score and APN, 
n (%) (95% CI)
Subjects with 
score, n(%)
Subjects with 
score and APN, 
n (%) (95% CI)
Relative Risk 
(95% CI)
Average 
Risk (0–2) 2,986 (76.8)
35 (1.2) 
(0.8–1.6) 1,504 (77.4)
23 (1.5) 
(1.0–2.3) 1.00
High Risk 
( >2) 903 (23.2)
69 (7.6) 
(6.0–9.6) 440 (22.6)
24 (5.5) 
(3.6–8.1)
3.57 
(2.03–6.26) 
P < 0.001
Total 3,889 (100) 104 (2.7) (2.2–3.2) 1,944 (100)
47 (2.4) 
(1.8–3.2)
Table 7.  Risk for APN, by Risk Group. APN: advanced proximal neoplasia, CI: confidence Interval.
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Conclusion
The new clinical index is a useful model to stratify risk for APN in Chinese population. A FS-based risk stratifi-
cation strategy is theoretically appealing, because the screening tests for lower risk individuals are less invasive, 
while colonoscopy could be reserved for those at higher risk. We recommend this scoring system should be exter-
nally validated in other population groups, and economic analysis be performed to study its cost-effectiveness.
Methods
Design. From January 2013 to December 2015, 11,554 colonoscopies were consecutively performed in a 
large endoscopic center of Ruijin Hospital North, Shanghai Jiaotong University. We recruited subjects who were 
referred by outpatient clinics and health assessment units of a major hospital, as well as screening participants 
under the government CRC screening program for colonoscopy. Individuals with visible bloody or abnormal 
stool, acute abdominal pain, abdominal mass, and the presence of CRC symptoms33 were excluded. CRC symp-
toms refer to haematochezia, malena, anorexia or a change in bowel habit in the past 4 weeks, or a weight loss of 
greater than 5 kg in the past 6 months. Participants from population-based CRC screening programs were all pos-
itive in immunochemical fecal occult blood tests (Kaichuang test strip (Nation Permission Number S20043085), 
100 ng/ml as cut off value) by screening strategy. Other exclusion criteria included those who failed to reach the 
cecum (n = 329), had poor bowel preparation (n = 124), had previous history of colorectal cancer (n = 378), 
were diagnosed as having ulcerative colitis and Crohn’s disease by endoscopy (n = 232), were diagnosed of other 
colorectal disease, like familial adenomatous polyposis, melanosis coli, or colic bleeding (n = 113) and took a 
surveillance colonoscopy (n = 743). Another 3,801 cases were excluded because they did not reach our recom-
mended age of screening (50–75 years old). Finally, there were 5,833 eligible cases enrolled in the study. All meth-
ods were performed in accordance with the relevant guidelines and regulations. The collection and use of clinical 
data was approved by the Research Ethics Committee of Ruijing Hospital North. Written informed consent was 
obtained from all patients before case enrollment.
Study Procedures, Definitions. Polyethylene glycol lavage solution was used for bowel preparation. 
Colonoscopy was performed by experienced endoscopists using a standard video colonoscopy. Complete colo-
noscopy is defined as intubation of the cecum with photo documentation of cecal landmarks. Participants with 
incomplete colonoscopy were excluded from the analysis. The size of a polyp was estimated by open-biopsy 
forceps before polypectomy was performed. The methods for assessing location were chosen by the endosco-
pist. Lesions located in the rectum, sigmoid, or descending colon were classified as distal, whereas those located 
in the splenic flexure, transverse colon, hepatic flexure, ascending colon, or cecum were classified as proximal. 
All polyps removed during colonoscopy were sent for histologic examination. Polyps considered too large for 
polypectomy and other suspicious lesions were biopsied. Histologic specimens are reviewed by a team of expert 
pathologists who are unaware of colonoscopy findings throughout the study. The reporting of histology for 
colorectal neoplasms is classified according to the criteria from the World Health Organization34. Advanced neo-
plasia was defined as invasive cancer, an adenoma sized at 10 mm or more, any lesions with at least 25% villous 
components, an adenoma with high-grade dysplasia, or cancer. Individuals with a pathologic interpretation of 
carcinoma in situ were classified as subjects with high-grade dysplasia. If either or both the proximal or distal 
colon had more than one polyp, the colonic lesion was categorized according to the most advanced finding.
Division plan and characteristics of derivation cohort and validation cohort. Based on this pre-
vious study, we randomly divided all eligible subjects into a derivation and validation cohort with a 2:1 ratio. 
Regarding the sample size of the validation cohort, we made reference to the study by Yeoh et al. in Asian coun-
tries, which indicated a minimum of 1,800 cases to attain a power of 80% for detection of a risk factor with OR of 
2 at an alpha level of 0.05. This is based on the estimated prevalence of advanced neoplasia of 4.5% in other Asian 
colorectal advanced neoplasia studies14,33,35.
Development of risk score from the derivation cohort. Univariate analysis was performed on the 
derivation cohort to examine the association between clinical risk factors, neoplasia, and advanced neoplasia. 
Variables associated with advanced neoplasia in univariate analyses (p < 0.05) were included in multivariate 
logistic regression analysis. For each risk factor, we assigned weightings in the risk score by using the respec-
tive adjusted ORs from the logistic regression analysis. The latter was halved and rounded to the nearest whole 
number to keep the total score as simple as possible. The risk score for an individual was the summation of their 
individual risk factors. The validity of the score and cut-off value were assessed by an AUC analysis.
Calculation and validation of the risk score (in validation cohort). Each subject in the validation 
group received a score which was the summation of individual scores based on the new index from the derivation 
cohort. According to the prevalence of APN in different scores, we separated the validation cohort into high risk 
(HR) and average risk (AR) group. The discrimination ability of the new index was examined by the c-statistics 
and the relative risk (RR) of APN in the HR group (versus AR group). The performance of the new index was 
evaluated by the AUC for prediction of APN.
Statistical analysis. The Cochran Mantel–Haenszel χ 2 tests were used for categorical data to compare pro-
portions of each candidate risk factor, including age, gender, and the most advanced distal findings. Univariate 
and multivariate binary logistic regression were applied to assess these predictors for APN. An AUC of > 0.8 and 
0.7–0.8 was considered to demonstrate excellent and good discriminatory performance, respectively. Significance 
was defined at the P < 0.05 level for all analysis. The 95% confidential interval (CI) was reported for all the propor-
tions. The Statistical Package for Social Science (SPSS) version 21.0 (Chicago, Illinois) was used for data analysis.
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